Page last updated: 2024-10-28

hydroxyurea and Brain Damage, Chronic

hydroxyurea has been researched along with Brain Damage, Chronic in 3 studies

Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sheth, S1
Licursi, M1
Bhatia, M1
Armstrong, FD1
Elkin, TD1
Brown, RC1
Glass, P1
Rana, S1
Casella, JF1
Kalpatthi, RV1
Pavlakis, S1
Mi, Z1
Wang, WC1
Schmugge, M1
Frischknecht, H1
Yonekawa, Y1
Baumgartner, RW1
Boltshauser, E1
Humbert, J1

Reviews

1 review available for hydroxyurea and Brain Damage, Chronic

ArticleYear
Sickle cell disease: time for a closer look at treatment options?
    British journal of haematology, 2013, Volume: 162, Issue:4

    Topics: Africa; Anemia, Sickle Cell; Brain Damage, Chronic; Cardiovascular Diseases; Chelation Therapy; Chro

2013

Trials

1 trial available for hydroxyurea and Brain Damage, Chronic

ArticleYear
Developmental function in toddlers with sickle cell anemia.
    Pediatrics, 2013, Volume: 131, Issue:2

    Topics: Activities of Daily Living; Adaptation, Psychological; Age Factors; Anemia, Sickle Cell; Antisicklin

2013

Other Studies

1 other study available for hydroxyurea and Brain Damage, Chronic

ArticleYear
Stroke in hemoglobin (SD) sickle cell disease with moyamoya: successful hydroxyurea treatment after cerebrovascular bypass surgery.
    Blood, 2001, Apr-01, Volume: 97, Issue:7

    Topics: Anemia, Sickle Cell; Aphasia; Blood Flow Velocity; Blood Transfusion; Brain Damage, Chronic; Brain I

2001